Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CCCCCCCC
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in C4 THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 3.5M shares of CCCC (C4 THERAPEUTICS INC), worth $16.5M as of 2026-Q2. The position was increased (+47.9% shares). CCCC represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$16.5M

Current Shares

3.5M

Total Value Change

+$14.4M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.5M
+47.9%
$16.5M0.0%$4.67
39
2026-Q1
Increased
2.4M
+119.2%
$6.3M0.0%$2.95
44
2025-Q4
Increased
1.1M
+136.8%
$2.1M0.0%$1.96
42
2025-Q3
Decreased
459,893
-47.8%
$1M0.0%$2.23
0
2025-Q2
Increased
880,258
+41.4%
$1.3M0.0%$1.40
34
2025-Q1
Increased
622,720
+8.6%
$996,3520.0%$1.75
27
2024-Q4
New
573,655
-
$2.1M0.0%$3.64
36

Other major holders of CCCC: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used